Prime Medicine (PRME) Assets Average (2022 - 2026)

Prime Medicine (PRME) has 5 years of Assets Average data on file, last reported at $318.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 1.88% year-over-year to $318.7 million; the trailing twelve-month figure through Mar 2026 stood at $318.7 million (up 1.88% YoY), and the FY2025 full-year result was $320.1 million, up 30.3% from the prior year.
• Assets Average for Q1 2026 stood at $318.7 million, down from $363.9 million in the prior quarter.
• Across five years, Assets Average topped out at $363.9 million in Q4 2025 and bottomed at $216.5 million in Q4 2023.
• The 5-year median for Assets Average is $301.2 million (2023), against an average of $298.7 million.
• Peak annual rise in Assets Average reached 45.57% in 2024, while the deepest fall reached 25.4% in 2024.
• A 5-year view of Assets Average shows it stood at $287.8 million in 2022, then dropped by 24.77% to $216.5 million in 2023, then jumped by 45.57% to $315.1 million in 2024, then increased by 15.46% to $363.9 million in 2025, then decreased by 12.41% to $318.7 million in 2026.
• The last three Assets Average figures came in at $318.7 million (Q1 2026), $363.9 million (Q4 2025), and $332.0 million (Q3 2025), per Business Quant data.

Peer Comparison